title: Absence of radiographic progression at two years in a cohort of patients with non-radiographic axial spondyloarthritis treated with TNF-α blockers.
authors.affiliation: Servicio de Reumatología, Parc de Salut Mar, Barcelona, España. Electronic address: reu0802@parcdesalutmar.cat.
authors.forename: Miriam
authors.initials: M
authors.lastname: Almirall
authors.affiliation: Servicio de Reumatología, Parc de Salut Mar, Barcelona, España.
authors.forename: Josue Guillermo
authors.initials: JG
authors.lastname: López-Velandia
authors.affiliation: Servicio de Reumatología, Parc de Salut Mar, Barcelona, España.
authors.forename: Joan
authors.initials: J
authors.lastname: Maymó
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D002574:Cervical Vertebrae / Q000000981:diagnostic imaging*; D018450:Disease Progression; D000068800:Etanercept; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D000069285:Infliximab; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging*; D008297:Male; D011859:Radiography; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012446:Sacroiliac Joint / Q000000981:diagnostic imaging*; D025241:Spondylarthritis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab; D000068800:Etanercept